Deals channel feed – Endpoints News

Deals channel feed

Regeneron buys London-based ocular biotech

4 months ago

Roche circles back to China biotech with $80M deal for lung cancer ADC

4 months ago

Deerfield wins fight to acquire Singular Genomics, beating out Tang Capital’s Concentra

4 months ago

Jim Wilson's GemmaBio raises $34M to commercialize gene therapies for rare diseases

4 months ago

PDUFAs for Tonix and Nuvation; Sanofi vaccine partnership; RAPT allergy deal

4 months ago

Immunology biotech Inmagene to join Nasdaq through reverse merger with what's left of Ikena

4 months ago

Commure's latest acquisition sends follow-up texts to patients

4 months ago

Tracer Biotechnologies raises $10M, partners with AstraZeneca

4 months ago

Aadi starts from scratch as it sells assets, licenses ADCs and raises new funds

4 months ago

Bristol Myers pays $100M upfront to collaborate with Leqembi originator in Alzheimer's

4 months ago

Sangamo strikes another brain-targeting AAV partnership, this time with Astellas

4 months ago

Merck’s long-awaited obesity move is an oral GLP-1 from China

4 months ago

Novartis turns to BioAge for new targets based on longevity and exercise

4 months ago

Novo Nordisk partners with Broad Institute spinout Photys after the startup's layoffs

4 months ago

What Trump’s FTC picks mean for biopharma dealmaking and PBMs

4 months ago

Bristol Myers drops cell therapy pacts with Immatics, Century as part of portfolio review

4 months ago

FTC OKs Novo-Catalent deal in major win for Novo Nordisk’s GLP-1 manufacturing

4 months ago

BeiGene licenses solid tumor drug, matches with Ideaya’s combo plans

4 months ago

AbbVie makes another small I&I acquisition, buying Nimble for $200M

4 months ago

Padlock shareholders sue Bristol Myers over milestone dispute after 2016 acquisition

5 months ago

The Endpoints 100: The biotech industry braces for Trump 2.0

5 months ago

Chroma, Nvelop merge to form nChroma Bio, raising $75M to enter the clinic

5 months ago

Bayer exits Europe pact with Moberg for nail fungus drug after Phase 3 fail

5 months ago

Walgreens in talks to sell to private equity — report

5 months ago

First page Previous page 4 5 678 9 10 Next page Last page